GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
Houston Methodist Hospital and Madison, Wis.-based UW Health are the first U.S. healthcare organizations to use GE Healthcare’s new PET radiotracer, Flyrcado. The radiopharmaceutical is a positron ...
USA: Positron emission tomography (PET) imaging may help identify patients at higher risk of developing atrial fibrillation (AF) by detecting increased metabolic activity in the atrial walls, a new ...
There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results